PCMA: IOM recommendations are timely

10/13/2011 | BNA (free content)

The Institute of Medicine's recommendations that HHS consider cost and affordability in determining which benefits insurers participating in exchanges must cover will ensure flexibility and have opened "a long-overdue debate between employers and some powerful special interests that benefit from costly new mandates," Pharmaceutical Care Management Association President and CEO Mark Merritt says.

New PCMA Ad: Small Businesses Oppose Costly Mandates Pushed by Drugstore, Drug Company Lobbies

View Full Article in:

BNA (free content)